Vebicorvir

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVebicorvir
Drug Alias NameABI-H0731ABIH-0731
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCore protein allosteric modifiers (CpAM)Capsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesIndiana University
China Registration ClassN/A

Develop Information

Active CompaniesAssembly Biosciences IncBeOne Medicines LtdPatheon Inc +[4] 
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A